KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $118,513,000 | +447.6% | 659,115 | +215.7% | 0.08% | +440.0% |
| Q2 2017 | $21,643,000 | +40.8% | 208,792 | +6.6% | 0.02% | +36.4% |
| Q1 2017 | $15,371,000 | +83.8% | 195,862 | +5.0% | 0.01% | +57.1% |
| Q4 2016 | $8,362,000 | -28.7% | 186,539 | -11.1% | 0.01% | -12.5% |
| Q3 2016 | $11,721,000 | +72.3% | 209,849 | +54.2% | 0.01% | +60.0% |
| Q2 2016 | $6,803,000 | +439.9% | 136,093 | +395.3% | 0.01% | +400.0% |
| Q1 2016 | $1,260,000 | -83.1% | 27,476 | -77.3% | 0.00% | -80.0% |
| Q4 2015 | $7,447,000 | +1181.8% | 120,874 | +1055.0% | 0.01% | – |
| Q3 2015 | $581,000 | +4.7% | 10,465 | +14.7% | 0.00% | – |
| Q2 2015 | $555,000 | -17.5% | 9,123 | -22.0% | 0.00% | – |
| Q1 2015 | $673,000 | +31.2% | 11,700 | +31.3% | 0.00% | – |
| Q4 2014 | $513,000 | – | 8,908 | +296833.3% | 0.00% | – |
| Q3 2014 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|